GRI-0621
N/A
Report date: 2024/03/05 15:25:59
Base Information
Drug NameGRI-0621
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGri Bio Inc
China Registration ClassN/A
Develop Information
Active CompaniesGRI Bio Operations IncGri Bio Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A